ÖÐÎÄÃû³Æ£ºÍÿ¹CCNL1¶à¿Ë¡¿¹Ìå
Ó¢ÎÄÃû³Æ£º Anti-CCNL1 rabbit polyclonal antibody
±ð Ãû£º ANIA6A; BM-001; PRO1073; ania-6a
Ïà¹ØÀà±ð£º Ò»¿¹
´¢ ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â
¿¹ Ô£º CCNL1
ËÞ Ö÷£º Rabbit
±ê ¼Ç Î Unconjugate
¿Ë¡ÀàÐÍ£º Unconjugate
¼¼Êõ¹æ¸ñ
|
Background: |
Transcriptional regulator which participates in regulating the pre-mRNA splicing process. Seems to be involved in the regulation of RNA polymerase II (pol II). Functions in association with cyclin-dependent kinases (CDKs) and has a role in the second step of splicing. May be a candidate proto-oncogene in head and neck squamous cell carcinomas (HNSCC). Inhibited by the CDK-specific inhibitor p21. |
|
Applications: |
WB, IHC |
|
Name of antibody: |
CCNL1 |
|
Immunogen: |
Synthesized peptide derived from human Cyclin-L1. |
|
Full name: |
cyclin L1 |
|
Synonyms£º |
ANIA6A; BM-001; PRO1073; ania-6a |
|
SwissProt: |
Q9UK58 |
|
IHC positive control: |
Human breast carcinoma tissue |
|
IHC Recommend dilution: |
50-100 |
|
WB Predicted band size: |
60 kDa |
|
WB Positive control: |
HepG2 cells lysate |
|
WB Recommended dilution: |
500-3000 |


¹ºÎï³µ
°ïÖú
021-54845833/15800441009
